Literature DB >> 27903111

Electrical Stimulation Enhances Cardiac Differentiation of Human Induced Pluripotent Stem Cells for Myocardial Infarction Therapy.

Ruilian Ma1, Jialiang Liang1, Wei Huang1, Linlin Guo1, Wenfeng Cai1, Lei Wang1, Christian Paul1, Huang-Tian Yang2, Ha Won Kim1, Yigang Wang1.   

Abstract

AIMS: Electrical stimulation (EleS) can promote cardiac differentiation, but the underlying mechanism is not well known. This study investigated the effect of EleS on cardiomyocyte (CM) differentiation of human induced pluripotent stem cells (hiPSCs) and evaluated the therapeutic effects for the treatment of myocardial infarction (MI).
RESULTS: Cardiac differentiation of hiPSCs was induced with EleS after embryoid body formation. Spontaneously beating hiPSCs were observed as early at 2 days when treated with EleS compared with control treatment. The cardiac differentiation efficiency of hiPSCs was significantly enhanced by EleS. In addition, the functional maturation of hiPSC-CMs under EleS was confirmed by calcium indicators, intracellular Ca2+ levels, and expression of structural genes. Mechanistically, EleS mediated cardiac differentiation of hiPSCs through activation of Ca2+/PKC/ERK pathways, as revealed by RNA sequencing, quantitative polymerase chain reaction, and Western blotting. After transplantation in immunodeficient MI mice, EleS-preconditioned hiPSC-derived cells significantly improved cardiac function and attenuated expansion of infarct size. The preconditioned hiPSC-derived CMs were functionally integrated with the host heart. INNOVATION: We show EleS as an efficacious time-saving approach for CM generation. The global RNA profiling shows that EleS can accelerate cardiac differentiation of hiPSCs through activation of multiple pathways. The cardiac-mimetic electrical signals will provide a novel approach to generate functional CMs and facilitate cardiac tissue engineering for successful heart regeneration.
CONCLUSION: EleS can enhance efficiency of cardiac differentiation in hiPSCs and promote CM maturation. The EleS-preconditioned CMs emerge as a promising approach for clinical application in MI treatment. Antioxid. Redox Signal. 28, 371-384.

Entities:  

Keywords:  calcium pathways; cardiomyocytes; cellular differentiation; electric stimulation; induced pluripotent stem cells; myocardial infarction

Mesh:

Year:  2017        PMID: 27903111      PMCID: PMC5770128          DOI: 10.1089/ars.2016.6766

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  69 in total

1.  Pharmacomechanical coupling in rat vas deferens: effects of agents that modulate intracellular release of calcium and protein kinase C activation.

Authors:  N I Amobi; D Sugden; I C Smith
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

Review 2.  Challenges in using stem cells for cardiac repair.

Authors:  Christine L Mummery; Richard P Davis; Jose E Krieger
Journal:  Sci Transl Med       Date:  2010-04-14       Impact factor: 17.956

3.  Another dimension to calcium signaling: a look at extracellular calcium.

Authors:  Aldebaran M Hofer
Journal:  J Cell Sci       Date:  2005-03-01       Impact factor: 5.285

4.  Regenerative medicine.

Authors:  Anthony Atala; Sean Murphy
Journal:  JAMA       Date:  2015-04-14       Impact factor: 56.272

5.  Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair.

Authors:  Yigang Wang; Husnain K Haider; Nauman Ahmad; Meifeng Xu; Ruowen Ge; Muhammad Ashraf
Journal:  J Mol Cell Cardiol       Date:  2006-05       Impact factor: 5.000

6.  Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming.

Authors:  Paul W Burridge; Gordon Keller; Joseph D Gold; Joseph C Wu
Journal:  Cell Stem Cell       Date:  2012-01-06       Impact factor: 24.633

Review 7.  Chromatin modifications remodel cardiac gene expression.

Authors:  Prabhu Mathiyalagan; Samuel T Keating; Xiao-Jun Du; Assam El-Osta
Journal:  Cardiovasc Res       Date:  2014-05-08       Impact factor: 10.787

8.  Combining neuropeptide Y and mesenchymal stem cells reverses remodeling after myocardial infarction.

Authors:  Yigang Wang; Dongsheng Zhang; Muhammad Ashraf; Tiemin Zhao; Wei Huang; Atif Ashraf; Ambikaipakan Balasubramaniam
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-11-06       Impact factor: 4.733

9.  Electrical stimulation of human embryonic stem cells: cardiac differentiation and the generation of reactive oxygen species.

Authors:  Elena Serena; Elisa Figallo; Nina Tandon; Christopher Cannizzaro; Sharon Gerecht; Nicola Elvassore; Gordana Vunjak-Novakovic
Journal:  Exp Cell Res       Date:  2009-08-29       Impact factor: 3.905

10.  Physiological conditioning by electric field stimulation promotes cardiomyogenic gene expression in human cardiomyocyte progenitor cells.

Authors:  Aida Llucià-Valldeperas; Benjamin Sanchez; Carolina Soler-Botija; Carolina Gálvez-Montón; Santiago Roura; Cristina Prat-Vidal; Isaac Perea-Gil; Javier Rosell-Ferrer; Ramon Bragos; Antoni Bayes-Genis
Journal:  Stem Cell Res Ther       Date:  2014-08-04       Impact factor: 6.832

View more
  19 in total

1.  CRISPR activation of endogenous genes reprograms fibroblasts into cardiovascular progenitor cells for myocardial infarction therapy.

Authors:  Lin Jiang; Jialiang Liang; Wei Huang; Jianyong Ma; Ki Ho Park; Zhichao Wu; Peng Chen; Hua Zhu; Jian-Jie Ma; Wenfeng Cai; Christian Paul; Liang Niu; Guo-Chang Fan; Hong-Sheng Wang; Onur Kanisicak; Meifeng Xu; Yigang Wang
Journal:  Mol Ther       Date:  2021-10-20       Impact factor: 11.454

Review 2.  Myocardial infarction from a tissue engineering and regenerative medicine point of view: A comprehensive review on models and treatments.

Authors:  Gozde Basara; Gokhan Bahcecioglu; S Gulberk Ozcebe; Bradley W Ellis; George Ronan; Pinar Zorlutuna
Journal:  Biophys Rev (Melville)       Date:  2022-08-30

Review 3.  Bioengineering approaches to mature induced pluripotent stem cell-derived atrial cardiomyocytes to model atrial fibrillation.

Authors:  Olivia T Ly; Grace E Brown; Yong Duk Han; Dawood Darbar; Salman R Khetani
Journal:  Exp Biol Med (Maywood)       Date:  2021-04-25

4.  Intracellular Calcium and Sodium Modulation of Self-Assembled Neocartilage Using Costal Chondrocytes.

Authors:  Gaston A Otarola; Jerry C Hu; Kyriacos A Athanasiou
Journal:  Tissue Eng Part A       Date:  2022-03-29       Impact factor: 4.080

Review 5.  Analyzing Impetus of Regenerative Cellular Therapeutics in Myocardial Infarction.

Authors:  Ming-Long Chang; Yu-Jui Chiu; Jian-Sing Li; Khoot-Peng Cheah; Hsiu-Hu Lin
Journal:  J Clin Med       Date:  2020-04-28       Impact factor: 4.241

Review 6.  L-type voltage-gated calcium channels in stem cells and tissue engineering.

Authors:  Yi-Zhou Tan; Dong-Dong Fei; Xiao-Ning He; Ji-Min Dai; Rong-Chen Xu; Xin-Yue Xu; Jun-Jie Wu; Bei Li
Journal:  Cell Prolif       Date:  2019-05-21       Impact factor: 6.831

Review 7.  Maturation strategies and limitations of induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Peng Wu; Gang Deng; Xiyalatu Sai; Huiming Guo; Huanlei Huang; Ping Zhu
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

Review 8.  The rationale and emergence of electroconductive biomaterial scaffolds in cardiac tissue engineering.

Authors:  Matteo Solazzo; Fergal J O'Brien; Valeria Nicolosi; Michael G Monaghan
Journal:  APL Bioeng       Date:  2019-10-15

9.  Electrically stimulable indium tin oxide plate for long-term in vitro cardiomyocyte culture.

Authors:  Sung-Hwan Moon; Young-Woo Cho; Hye-Eun Shim; Jae-Hak Choi; Chan-Hee Jung; In-Tae Hwang; Sun-Woong Kang
Journal:  Biomater Res       Date:  2020-05-27

10.  Cardiac-mimetic cell-culture system for direct cardiac reprogramming.

Authors:  Seuk Young Song; Jin Yoo; Seokhyeong Go; Jihye Hong; Hee Su Sohn; Ju-Ro Lee; Mikyung Kang; Gun-Jae Jeong; Seungmi Ryu; Seung Hyun L Kim; Nathaniel S Hwang; Kookheon Char; Byung-Soo Kim
Journal:  Theranostics       Date:  2019-09-19       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.